美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

REVOLUTION MEDICINES INC C/WTS (TO PUR COM)

1.64

-0.2300-12.30%

成交量：1,000.00

成交額：1,640.04

市值：3.07億

市盈率：-0.32

高：1.64

開：1.64

低：1.64

收：1.87

52周最高：3.59

52周最低：0.0305

股本：1.87億

流通股本：1.87億

量比：0.95

換手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-5.1779

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

REVOLUTION MEDICINES INC C/WTS (TO PUR COM)

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.revmed.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Revolution Medicines, Inc.成立於2014年10月，是特拉華州的一家公司。該公司是一家臨床階段的精準腫瘤學公司，專註於開發靶向療法，以抑制RAS成癮癌症的前沿靶點。該公司擁有先進的基於結構的藥物發現能力，其基礎是深厚的化學生物學和癌症藥理學知識以及創新的專有技術，能夠創造適合非常規結合位點的小分子。該公司對癌症的遺傳驅動因素和適應性耐藥機制的了解，加上強大的藥物發現和藥物化學能力，指導建立了一個針對RAS通路和相關通路中的關鍵信號節點的深層管道。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RVMDW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RVMDW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVMDW\",,,,,undefined,":{"symbol":"RVMDW","market":"US","secType":"STK","nameCN":"REVOLUTION MEDICINES INC C/WTS (TO PUR COM)","latestPrice":1.64,"timestamp":1774446791216,"preClose":1.87,"halted":0,"volume":1000,"delay":0,"changeRate":-0.12299465240641722,"floatShares":186933192,"shares":186933192,"eps":-5.1779,"marketStatus":"交易中","change":-0.23,"latestTime":"03-25 09:53:50 EDT","open":1.64,"high":1.64,"low":1.64,"amount":1640.04,"amplitude":0,"askPrice":1.77,"askSize":200,"bidPrice":1.5,"bidSize":240,"shortable":0,"etf":0,"ttmEps":-5.1779,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774468800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.87,"volumeRatio":0.951361},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVMDW\",,,,,undefined,":{"symbol":"RVMDW","floatShares":186933192,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.951361,"shares":186933192,"dividePrice":0,"high":1.64,"amplitude":0,"preClose":1.87,"low":1.64,"week52Low":0.0305,"pbRate":"--","week52High":3.5899,"institutionHeld":0,"latestPrice":1.64,"committee":0.090909,"eps":-5.1779,"divideRate":0,"volume":1000,"delay":0,"ttmEps":-5.1779,"open":1.64,"prevYearClose":0.9399,"prevWeekClose":1.6,"prevMonthClose":2.16,"prevQuarterClose":0.9399,"fiveDayClose":1.93,"twentyDayClose":2.02,"sixtyDayClose":0.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RVMDW\",params:#limit:5,,,undefined,":[{"date":"2026-02-25","symbol":"RVMDW","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772053200000,"name":null,"time":"盤後","dateTimestamp":1771995600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RVMDW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RVMDW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.revmed.com","stockEarnings":[{"period":"1week","weight":-0.0169},{"period":"1month","weight":-0.0278},{"period":"3month","weight":0.8229},{"period":"6month","weight":5.3521},{"period":"1year","weight":17.6368},{"period":"ytd","weight":0.8619}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Revolution Medicines, Inc.成立於2014年10月，是特拉華州的一家公司。該公司是一家臨床階段的精準腫瘤學公司，專註於開發靶向療法，以抑制RAS成癮癌症的前沿靶點。該公司擁有先進的基於結構的藥物發現能力，其基礎是深厚的化學生物學和癌症藥理學知識以及創新的專有技術，能夠創造適合非常規結合位點的小分子。該公司對癌症的遺傳驅動因素和適應性耐藥機制的了解，加上強大的藥物發現和藥物化學能力，指導建立了一個針對RAS通路和相關通路中的關鍵信號節點的深層管道。","exchange":"NASDAQ","name":"REVOLUTION MEDICINES INC C/WTS (TO PUR COM)","nameEN":"REVOLUTION MEDICINES INC C/WTS (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RVMDW\",market:\"US\",,,undefined,":null}}